Anal Carcinoma clinical trials
37 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
- HPV ctDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Advanced-Stage Anal Cancer
- Utero-ovarian Transposition in Patients With Pelvic Malignancies Undergoing Whole Pelvic Radiotherapy
- E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers
- E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers
- Pomalidomide and Nivolumab in People With Virus-Associated Malignancies With or Without HIV
- Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and Paclitaxel
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
- SMP-3124LP in Adults With Advanced Solid Tumors
- At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer
- Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- Self-sampling to Optimize Anal Lesion Outcomes
- Screening Women With Prior HPV for Anal Neoplasia
- Detecting HPV DNA in Anal and Cervical Cancers
- DESTINY-PANTUMOUR04
- Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- A Multi Center Study of Sexual Toxicities After Radiotherapy
- Integrated Cancer Repository for Cancer Research
- Tissue Procurement for Gastric Cancer, Gastrointestinal Stromal Tumors (GIST), Esophageal Cancer, Pancreas Cancer, Hepatocellular Cancer, Biliary Cancer, Neuroendocrine, Peritoneal Mesothelioma, Anal Cancer and Colorectal Cancer in Patients Undergoing Surgery or Biopsy
- Ganglion Impar Neurolysis for the Improvement of Radiation-Induced Pain During Localized Anal or Perianal Skin Cancer Treatment
- Distance-Based Exercise to Preserve Function and Prevent Disability
- BOLSTER: Learning New Skills to Thrive
- Pilot Study of Fisetin to Improve Fatigue Among Older Adult Cancer Survivors
- Vaginal Dilator Therapy After Pelvic Radiation
- Resilience and Equity in Aging, Cancer, and Health (REACH)
- Vaginal DHEA to Improve Vaginal Health After Radiation for Women With Gynecologic, Anal or Rectal Cancer
- Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy
- EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer.
- Oral 5 Strain Probiotic for GI Toxicity Mitigation During Pelvic Radiation
- Pre-Rehabilitation for Female Patients Undergoing Pelvic Radiotherapy
- Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
- COQ10 and Vitamin E for Off-Target Radiation Toxicity
- Improving Clinic Delivery of HIV-related Anal Health Services
- Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers
- ASSESSING THE GAY MALE EXPERIENCE WITH ANAL CANCER PREVENTION STRATEGIES
- Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Anal Carcinoma” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.